Document is current
Any future updates will be listed below
-
Authors
Liu, Yingxin
Li, Zemin
Wang, Ruoting
Zhang, Jingyi
Gerstein, Hertzel
Zhao, Ai
Zhang, Changfa
Lip, Gregory Y. H.
Van Spall, Harriette G. C.
Li, Guowei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82473612)
Natural Science Foundation of Guangdong Province of China (2025A1515010779)
Science Foundation of Guangdong Second Provincial General Hospital (YY2018-002)
Young Top Talent Project in Special Support Plan for Training High-level Talents in Guangdong (0720240244)
- License Information
-
More Information
Article History
Received: 22 May 2025
Accepted: 8 September 2025
First Online: 3 October 2025
Declarations
:
: The UK Biobank study was approved by the North West Multicenter Research Ethics Committee. All participants provided written consent before enrolment.
: GYHL served as a consultant for Novartis, Bayer/Janssen, Biotronik, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Verseon, and Daiichi-Sankyo and as a speaker for Medtronic, Bayer, BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No fees have been received directly or personally. All other authors have declared no conflicts of interest.
